Glut1 deficiency is a rare but treatable cause of childhood absence epilepsy with atypical features

Epilepsy Res. 2019 Aug:154:39-41. doi: 10.1016/j.eplepsyres.2019.04.003. Epub 2019 Apr 21.

Abstract

Glucose transporter type 1 deficiency syndrome (GLUT1-DS) is a rare genetic disorder caused by pathogenic variants in SLC2A1, resulting in impaired glucose uptake through the blood-brain barrier. Our objective is to analyze the frequency of GLUT1-DS in patients with absences with atypical features. Sequencing analysis and detection of copy number variation of the SLC2A1 gene was carried out in patients with atypical absences including: early-onset absence, intellectual disability, additional seizure types, refractory epilepsy, associated movement disorders, as well as those who have first-degree relatives with absence epilepsy or atypical EEG ictal discharges. Of the 43 patients analyzed, pathogenic variations were found in 2 (4.6%). Six atypical characteristics were found in these 2 patients. The greater the number of atypical characteristics presenting in patients with absence seizures, the more likely they have a SLC2A1 mutation. Although GLUT1-DS is an infrequent cause of absence epilepsy, recognizing this disorder is important, since initiation of a ketogenic diet can reduce the frequency of seizures, the severity of the movement disorder, and also improve the quality of life of the patients and their families.

Keywords: Absence epilepsy; Early onset absence epilepsy (EOAE); Glucose transporter type 1 deficiency syndrome (GLUT1-DS); SLC2A1.

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Carbohydrate Metabolism, Inborn Errors / complications*
  • Carbohydrate Metabolism, Inborn Errors / diet therapy
  • Carbohydrate Metabolism, Inborn Errors / genetics*
  • Child
  • Child, Preschool
  • Cohort Studies
  • Diet, Ketogenic / methods
  • Epilepsy, Absence / diet therapy
  • Epilepsy, Absence / etiology*
  • Epilepsy, Absence / genetics*
  • Female
  • Genetic Variation / genetics*
  • Glucose Transporter Type 1 / genetics*
  • Humans
  • Male
  • Middle Aged
  • Monosaccharide Transport Proteins / deficiency*
  • Monosaccharide Transport Proteins / genetics
  • Treatment Outcome
  • Young Adult

Substances

  • Glucose Transporter Type 1
  • Monosaccharide Transport Proteins
  • SLC2A1 protein, human

Supplementary concepts

  • Glut1 Deficiency Syndrome